Catalyst Wire Dossier Catalyst Wire Dossier

Ganciclovir 0.15% ophthalmic gel

ganciclovir · Bausch & Lomb
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ganciclovir 0.15% ophthalmic gel, covering 2011-05-06 to 2011-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis [NA]

See pricing